LY3537982

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for LY3537982, covering 2024-11-08 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney Function [Phase 1]

See pricing